195 related articles for article (PubMed ID: 22943629)
1. Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings.
Briani C; Campagnolo M; Lucchetta M; Cacciavillani M; Dalla Torre C; Granata G; Bergamo F; Lonardi S; Zagonel V; Cavaletti G; Ermani M; Padua L
Eur J Neurol; 2013 Jan; 20(1):188-92. PubMed ID: 22943629
[TBL] [Abstract][Full Text] [Related]
2. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies.
Krøigård T; Schrøder HD; Qvortrup C; Eckhoff L; Pfeiffer P; Gaist D; Sindrup SH
Eur J Neurol; 2014 Apr; 21(4):623-9. PubMed ID: 24460946
[TBL] [Abstract][Full Text] [Related]
3. Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.
Velasco R; Bruna J; Briani C; Argyriou AA; Cavaletti G; Alberti P; Frigeni B; Cacciavillani M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Kalofonos HP
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):392-8. PubMed ID: 23813745
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study.
Kokotis P; Schmelz M; Kostouros E; Karandreas N; Dimopoulos MA
Clin Colorectal Cancer; 2016 Sep; 15(3):e133-40. PubMed ID: 27038553
[TBL] [Abstract][Full Text] [Related]
5. Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
McHugh JC; Tryfonopoulos D; Fennelly D; Crown J; Connolly S
Eur J Cancer Care (Engl); 2012 Nov; 21(6):782-9. PubMed ID: 22594346
[TBL] [Abstract][Full Text] [Related]
6. Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study.
Briani C; Argyriou AA; Izquierdo C; Velasco R; Campagnolo M; Alberti P; Frigeni B; Cacciavillani M; Bergamo F; Cortinovis D; Cazzaniga M; Bruna J; Cavaletti G; Kalofonos HP
J Peripher Nerv Syst; 2014 Dec; 19(4):299-306. PubMed ID: 25582667
[TBL] [Abstract][Full Text] [Related]
7. A review on oxaliplatin-induced peripheral nerve damage.
Argyriou AA; Polychronopoulos P; Iconomou G; Chroni E; Kalofonos HP
Cancer Treat Rev; 2008 Jun; 34(4):368-77. PubMed ID: 18281158
[TBL] [Abstract][Full Text] [Related]
8. Ulnar neuropathy in hansen disease: clinical, high-resolution ultrasound and electrophysiologic correlations.
Bathala L; Kumar K; Pathapati R; Jain S; Visser LH
J Clin Neurophysiol; 2012 Apr; 29(2):190-3. PubMed ID: 22469686
[TBL] [Abstract][Full Text] [Related]
9. Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.
Argyriou AA; Briani C; Cavaletti G; Bruna J; Alberti P; Velasco R; Lonardi S; Cortinovis D; Cazzaniga M; Campagnolo M; Santos C; Kalofonos HP
Eur J Neurol; 2013 May; 20(5):788-94. PubMed ID: 23252594
[TBL] [Abstract][Full Text] [Related]
10. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-induced neurotoxicity and the development of neuropathy.
Krishnan AV; Goldstein D; Friedlander M; Kiernan MC
Muscle Nerve; 2005 Jul; 32(1):51-60. PubMed ID: 15880395
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and electrophysiological studies of oxaliplatin-induced peripheral neuropathy].
Liu LZ; Wu JY; Wu ZY; Chen ZH; Ling L; Sun B; Li YF; Huang XS
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1021-5. PubMed ID: 27055794
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.
Lehky TJ; Leonard GD; Wilson RH; Grem JL; Floeter MK
Muscle Nerve; 2004 Mar; 29(3):387-92. PubMed ID: 14981738
[TBL] [Abstract][Full Text] [Related]
15. Acute oxaliplatin-induced peripheral nerve hyperexcitability.
Wilson RH; Lehky T; Thomas RR; Quinn MG; Floeter MK; Grem JL
J Clin Oncol; 2002 Apr; 20(7):1767-74. PubMed ID: 11919233
[TBL] [Abstract][Full Text] [Related]
16. [Subclinical lesions of peripheral nervous system in multiple sclerosis patients].
Pogorzelski R; Baniukiewicz E; Drozdowski W
Neurol Neurochir Pol; 2004; 38(4):257-64. PubMed ID: 15383952
[TBL] [Abstract][Full Text] [Related]
17. Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signs.
Krøigård T; Svendsen TK; Wirenfeldt M; Schrøder HD; Qvortrup C; Pfeiffer P; Gaist D; Sindrup SH
Eur J Neurol; 2020 Jan; 27(1):68-76. PubMed ID: 31373417
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound of the peripheral nerves in systemic vasculitic neuropathies.
Grimm A; Décard BF; Bischof A; Axer H
J Neurol Sci; 2014 Dec; 347(1-2):44-9. PubMed ID: 25262016
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
[TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
Tofthagen C; McAllister RD; McMillan SC
Clin J Oncol Nurs; 2011 Apr; 15(2):182-8. PubMed ID: 21444285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
